Holen Sie sich die Stockscreener-App
48.30
0.91%
0.80
Schlusskurs vom Vortag:
$47.50
Offen:
$47.9
24-Stunden-Volumen:
289
Relative Volume:
0.03
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.96%
1M Leistung:
+1.67%
6M Leistung:
+32.70%
1J Leistung:
+16.45%
1-Tages-Spanne:
$47.90
$48.30
1-Wochen-Bereich:
$45.12
$48.92
52-Wochen-Spanne:
$27.20
$48.92
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GNOM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
48.30 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.60 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.42 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
271.31 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
622.35 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
(GNOM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Archford Capital Strategies LLC Sells 21,216 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Armbruster Capital Management Inc. Has $54.56 Million Holdings in Vanguard U.S. Value Factor $VFVA - Defense World
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Global X FundsGlobal X Genomics & Biotechnology ETF announces Semi-Annual dividend, payable on January 07, 2026 - marketscreener.com
Acacia Research (NASDAQ:ACTG) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The Next Big Theme: December 2025 - Seeking Alpha
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Touchstone Climate Transition ETF (OTCMKTS:HEAT) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
5 Small-cap Biotech ETFs to Watch - Investing News Network
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
Flow Traders U.S. LLC Buys 82,063 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Flow Traders U.S. LLC Has $1.71 Million Position in Avantis Short-Term Fixed Income ETF $AVSF - Defense World
Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Biglari (NYSE:BH) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The Next Big Theme: November 2025 - Seeking Alpha
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Flowserve (NYSE:FLS) Rating Lowered to Buy at Wall Street Zen - Defense World
Why (GNOM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Understanding Momentum Shifts in (GNOM) - news.stocktradersdaily.com
Atria Investments Inc Boosts Stake in Global X Genomics & Biotechnology ETF $GNOM - Defense World
Global X Genomics & Biotechnology ETF (GNOM) Stock Price Quote Today & Current Price Chart - Capital.com
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
Biotechnology: Pioneering The Future Of Medicine - Seeking Alpha
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Biotechnology: Pioneering the Future of Medicine - Global X ETFs
The Convergence Investor’s Cheat Sheet: 127 Companies Positioned at the Intersection of Future Technologies - DataDrivenInvestor
Astoria US Quality Growth Kings ETF (NASDAQ:GQQQ) Sees Large Increase in Short Interest - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update - Defense World
First Trust Health Care AlphaDEX Fund (NYSEARCA:FXH) Short Interest Up 187.5% in September - Defense World
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
The Next Big Theme: October 2025 - Global X ETFs
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - MSN
The Best Biotech ETFs to Buy - Kiplinger
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
The Next Big Theme: September 2025 - Global X ETFs
6 Best AI Drug Discovery Stocks in 2025 - StocksToTrade
HighTower Advisors LLC Acquires 2,184 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Re-rating Opportunities in Health Care Amid Sector Rotation and Regulatory Risk - AInvest
Investment Guide to Genetics Stocks and ETFs - NAI500
Investing in the DNA of Tomorrow: Explore Gene Stocks and Genomics ETFs - Investing News Network
How to Invest in Gene Stocks and ETFs - Nasdaq
The Next Big Theme: August 2025 - Seeking Alpha
Global X Announces Five ETF Reverse Stock Splits - Eastern Progress
7 Best Biotech ETFs to Buy Now - US News Money
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):